<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="794">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05150821</url>
  </required_header>
  <id_info>
    <org_study_id>IC_2021_KNN</org_study_id>
    <nct_id>NCT05150821</nct_id>
  </id_info>
  <brief_title>Impact of Covid-19 in the Emergency Department</brief_title>
  <official_title>Impact of Covid-19 in the Emergency Department in a Tertiary Care Hospital, Nuremberg-Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Panagiota Manava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Paracelsus Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of lockdown in the Emergency Department in a tertiary health care&#xD;
      hospital, Nuremberg, Germany.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the effect of the first lockdown caused by the pandemic of Covid-19 in a&#xD;
      tertiary health care hospital. Klinikum Nuremberg is one of the largest tertiary health care&#xD;
      hospitals in Germany with two locations in Nuremberg. In the north department, around 150&#xD;
      outcome patients visit the Emergency Department every day.&#xD;
&#xD;
      During the pandemic in 2020 the capacities of the hospitals were saved for the patients with&#xD;
      Covid-19. A decrease of patients presented in the ED was noticed. Controlling system and&#xD;
      patient management provided the number of cases and correlated with the same period of time&#xD;
      one year ago, before the pandemic.&#xD;
&#xD;
      For the classification of severity of diseases, different clinical diseases with severity&#xD;
      scores were analyzed. Following diseases and scores were evaluated:&#xD;
&#xD;
      Pancreatitis -- &gt; ranson score; ACS (acute coronary syndrome) --&gt; Grace-Score; Pulmonary&#xD;
      Embolism -- &gt; sPESI (simplified Pulmonary Embolism Severity Index); Diverticulitis --&gt; CDD&#xD;
      (Classification of Diverticular Disease); Pneumonia -&gt; crb65 (Confusion- Respiratory rate-&#xD;
      Blood pressure- age ≥ 65 years);&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ranson score</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>clinical severity index of pancreatitis. Estimates mortality of patients with pancreatitis, based on initial and 48-hour lab values. Min. 0 - Max. 11 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Grace-Score</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>clinical severity index of ACS. Estimates admission untill 6 month mortality for patients with acute coronary syndrome. 108 points: low risk. Over 141-372 points: high risk.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sPESI</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>clinical severity index of pulmonary embolism. Predicts 30-day outcome of patients with pulmonary embolism. Min 0 points- max. 6 points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>crb65</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>The CRB-65-score is a clinical score that is used to estimate the severity of community-acquired pneumonias. The score corresponds to the statistical probability of patients dying because of pneumonia. Min 0 points - highest score 4 points.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CDD</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>clinical severity index of diverticulitis. Min 0 - max. 4</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300000</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>experimental</arm_group_label>
    <description>patients during lockdown</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>patients before lockdown</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        the study population will be patients of a teriary care clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Only patients who presented in the ED.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Radiology and Nuclear Medicine</name>
      <address>
        <city>Nuremberg</city>
        <state>Bavaria</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Panagiota Manava, Dr.</last_name>
      <phone>+49 911 398 114930</phone>
      <email>panagiota.manava@klinikum-nuernberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael M. Lell, Prof. Dr.</last_name>
      <phone>+49 911 398 2540</phone>
      <email>michael.lell@klinikum-nuernberg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hwee J, Chiew J, Sechachalam S. The Impact of Coronavirus Disease 2019 (COVID-19) on the Practice of Hand Surgery in Singapore. J Hand Surg Am. 2020 Jun;45(6):536-541. doi: 10.1016/j.jhsa.2020.04.023. Epub 2020 Apr 29. Review.</citation>
    <PMID>32387156</PMID>
  </reference>
  <reference>
    <citation>Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, Fang J, Tse HF, Siu CW. Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):E194-E197. doi: 10.1002/ccd.28943. Epub 2020 May 5.</citation>
    <PMID>32367683</PMID>
  </reference>
  <reference>
    <citation>Wexner SD, Cortés-Guiral D, Gilshtein H, Kent I, Reymond MA. COVID-19: impact on colorectal surgery. Colorectal Dis. 2020 Jun;22(6):635-640. doi: 10.1111/codi.15112. Epub 2020 May 22.</citation>
    <PMID>32359223</PMID>
  </reference>
  <reference>
    <citation>Morgan C, Ahluwalia AK, Aframian A, Li L, Sun SNM. The impact of the novel coronavirus on trauma and orthopaedics in the UK. Br J Hosp Med (Lond). 2020 Apr 2;81(4):1-6. doi: 10.12968/hmed.2020.0137. Epub 2020 Apr 10.</citation>
    <PMID>32343187</PMID>
  </reference>
  <reference>
    <citation>Wang Y, Han W, Pan L, Wang C, Liu Y, Hu W, Zhou H, Zheng X. Impact of COVID-19 on blood centres in Zhejiang province China. Vox Sang. 2020 Aug;115(6):502-506. doi: 10.1111/vox.12931. Epub 2020 Apr 29.</citation>
    <PMID>32347566</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 7, 2021</study_first_submitted>
  <study_first_submitted_qc>December 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 8, 2021</last_update_submitted>
  <last_update_submitted_qc>December 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Paracelsus Medical University</investigator_affiliation>
    <investigator_full_name>Dr. Panagiota Manava</investigator_full_name>
    <investigator_title>Dr. med. Panagiota Manava, MD, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

